HLB

Google News EN

HLB nears FDA approval for bile duct cancer drug after smooth final review - CHOSUNBIZ - Chosunbiz

Thu, 23 Jul 2026 23:51:00 GMT

Google News EN

VAI rating resets HLB liver cancer drug bid but four hurdles loom - CHOSUNBIZ - Chosunbiz

Thu, 23 Jul 2026 21:21:00 GMT

Google News EN

HLB Unit Immunomic Doses First Patient in U.S. Phase 1 Cancer Vaccine Trial - Seoul Economic Daily

Mon, 20 Jul 2026 00:33:25 GMT

Google News EN

HLB's Liver Cancer Drug Clears FDA Manufacturing Hurdle; Group Stocks Surge for Second Day - finance.biggo.com

Thu, 16 Jul 2026 07:06:00 GMT

Google News EN Broad

HLB Shakes Off 'Limit-Down Nightmare' as 8 Group Stocks Hit Ceiling - Seoul Economic Daily

Wed, 15 Jul 2026 04:54:39 GMT

Google News EN

HLB Says Key Cause of Liver Cancer Drug CRL Resolved as FDA Classifies Chinese API Plant Inspection as VAI; Group Shares Surge - finance.biggo.com

Wed, 15 Jul 2026 01:45:00 GMT

Google News EN

HLB Secures FDA Inspection Findings, Formally Launches Re-application for Liver Cancer Drug - finance.biggo.com

Mon, 13 Jul 2026 15:36:00 GMT

Google News EN Broad

As HLB's stock price plunged due to unfavorable factors related to new drugs, the market capitalizat.. - 매일경제

Mon, 13 Jul 2026 07:00:00 GMT

Google News EN

HLB and Peptron Hit Daily Limit Down in Tandem — A Trigger for a K-Bio Trust Crisis? - finance.biggo.com

Sun, 12 Jul 2026 07:55:00 GMT

Google News EN Broad

HLB group stocks sink in South Korea after FDA rejects liver cancer drug - CHOSUNBIZ - Chosunbiz

Fri, 10 Jul 2026 07:00:00 GMT

Google News EN

HLB Plunges to Daily Limit as FDA Issues Third Rejection for Liver Cancer Drug; Group Stocks Wiped Out - finance.biggo.com

Thu, 09 Jul 2026 07:00:00 GMT

Google News EN

HLB Moves to Calm Stock Slide Ahead of FDA Decision - Seoul Economic Daily

Thu, 11 Jun 2026 07:00:00 GMT

Google News EN Broad

BlackRock takes 5% stake in HLB amid FDA review - The Korea Herald

Wed, 04 Mar 2026 08:00:00 GMT

Google News EN Broad

Investors dump Korean biotech HLB stocks on FDA rejection - KED Global

Fri, 17 May 2024 07:00:00 GMT